IL-12 stimulates the secretion of multiple cytokines, including IFN-γ, resulting in the activation of innate and adaptive immunity against cancer; however excessive or prolonged IL-12 signaling has been associated with immune-related toxicity and systemic inflammation (38, 39). This evidence concerns the gene IFNG and cancer.